Phase 2 N=20 Combination Facial Aesthetic Treatment in Millennials
Dermatological Non-Disease
Primary: FACE-Q Satisfaction With Facial Appearance Overall Scale — 42.35; 59.42 score on a scale
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=59 A Study to Evaluate Participant Satisfaction With Facial Appearance Overall and the Aesthetic and Psychosocial Impact of Combined Facial Treatment
Facial Rhytides, Skin Folds, Loss of Volume and Skin Quality
Primary: Change From Baseline in Rasch-transformed Score of FACE-Q Satisfaction With Facial Appearance Overall Scale to End of Study — 40.9; 37.8; 21.5; 32.9 score on a scale…
Phase 4 N=64 Study to Evaluate Subject Satisfaction With Facial Appearance and Impact of Combined Facial Treatment
Facial Rhytides · Skin Folds · Loss of Volume and Skin Quality
Primary: Change From Baseline in the Rasch-transformed Score of the FACE-Q Satisfaction With Facial Appearance Scale. — 46.6 units on a scale — p=<0.0001
Phase 3 N=25 Assess Aesthetic Improvement With QM1114-DP in Subjects With Moderate to Severe Lateral Canthal Lines and Glabellar Lines
Glabellar Frown Lines · Canthal Lines
Primary: Responders Rate Using the Global Aesthetic Improvement Scale (GAIS) at Maximum Frown (Glabellar Lines) — 100 percentage of participants
Phase 3 N=60 Subjects' Satisfaction on Pan Facial Aesthetic Enhancement After Treatment With Azzalure® and the Restylane® Range
Aging
Primary: Subject Satisfaction for the Full Face — 92.9; 7.1 percentage of total subjects
Phase 4 N=101 Prospective Evaluation of Facial Cosmetic Procedures
Cosmetic Techniques
Primary: Patient Satisfaction With Validated FACE-Q Aesthetics Survey — 28.0; 24.0; 36.0; 36.0 score on a scale
Phase 4 N=46 Esthetic Outcomes Following Immediate Implant Combine With Soft Tissue Augmentation
Dental Implant · Immediate Dental Implant · Soft Tissue Augmentation
Primary: Change in Ridge Dimension — -1.65; -1.87; -1.44; -1.37 millimeters (mm)
Phase 3 N=132 Assess Aesthetic Improvement and Onset of QM1114-DP in Subjects With Moderate to Severe Glabellar Lines
Glabellar Frown Lines
Primary: Number of Responders Using the Global Aesthetic Improvement Scale (GAIS) at Month 1 — 92; 3 Participants — p=<0.001
N/A N=60 Study to Evaluate Satisfaction After Treatment With Restylane
Cheek Augmentation
Primary: Assess Treatment With Restylane Volyme and Restylane Lyft Lidocaine Using GAIS — 20; 17; 9; 9 Participants